A silver bullet in a golden age of functional genomics: the impact of Agrobacterium-mediated transformation of fungi
Year: 2017
Type: review
Abstract: The implementation of Agrobacterium tumefaciens as a transformation tool revolutionized approaches to discover and understand gene functions in a large number of fungal species. A. tumefaciens mediated transformation ( At MT) is one of the most transformative technologies for research on fungi developed in the last 20 years, a development arguably only surpassed by the impact of genomics. At MT has been widely applied in forward genetics, whereby generation of strain libraries using random T-DNA insertional mutagenesis, combined with phenotypic screening, has enabled the genetic basis of many processes to be elucidated. Alternatively, At MT has been fundamental for reverse genetics, where mutant isolates are generated with targeted gene deletions or disruptions, enabling gene functional roles to be determined. When combined with concomitant advances in genomics, both forward and reverse approaches using At MT have enabled complex fungal phenotypes to be dissected at the molecular and genetic level. Additionally, in several cases At MT has paved the way for the development of new species to act as models for specific areas of fungal biology, particularly in plant pathogenic ascomycetes and in a number of basidiomycete species. Despite its impact, the implementation of At MT has been uneven in the fungi. This review provides insight into the dynamics of expansion of new research tools into a large research community and across multiple organisms. As such, At MT in the fungi, beyond the demonstrated and continuing power for gene discovery and as a facile transformation tool, provides a model to understand how other technologies that are just being pioneered, e.g. CRISPR/Cas, may play roles in fungi and other eukaryotic species.
Source: Fungal Biology and Biotechnology
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
SDG: Zero hunger
Open Access status: gold
Estimated APC paid: $2,590
Funders: Procter and Gamble, Grains Research and Development Corporation, Technische Universität Berlin, National Institutes of Health, Directorate for Biological Sciences, Biotechnology and Biological Sciences Research Council, Australian Research Council, National Institute of Allergy and Infectious Diseases
OpenAlex ID: W2760259192
